tirzepatide micro dose Instructions for Microdosing Compounded Tirzepatide+ Tirzepatide Microdosing Therapy - CoreAge

Ongoing treatment: If well-tolerated, increase to 0.5 mg once weekly starting from week 5

Genetic variation in the GLP1R, GIPR, FTO, and MC4R genes influences how your body responds to GLP-1 therapy

Usually mild and temporary (nausea, reduced appetite)

[108,129,367,369] A cross-sectional survey involving 115,229 hypertensive patients from 21 cities in China showed that the average resting heart rate among Chinese hypertensive patients was 76.6 beats/min, with 38.2% of those with isolated hypertension having a heart rate 80 beats/min

10.1016/S0002-9440(10)63408-6 70 KharbandaK

The mechanism appears to involve both direct brain effectsGLP-1 receptors are present in regions governing attention and memoryand indirect metabolic improvements that reduce neuroinflammation